See more : Baby Bunting Group Limited (BBN.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Kopran Limited (KOPRAN.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kopran Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Anton Oilfield Services Group (ATONF) Income Statement Analysis – Financial Results
- Continental Holdings Limited (0513.HK) Income Statement Analysis – Financial Results
- Scottie Resources Corp. (SCOT.V) Income Statement Analysis – Financial Results
- Life Travel & Tourist Service Co., Ltd. (2745.TWO) Income Statement Analysis – Financial Results
- Vertoz Advertising Limited (VERTOZ.NS) Income Statement Analysis – Financial Results
Kopran Limited (KOPRAN.NS)
About Kopran Limited
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.10B | 5.51B | 4.74B | 4.81B | 3.50B | 3.49B | 3.05B | 3.10B | 2.96B | 3.26B | 3.03B | 2.50B | 1.99B | 1.95B | 1.64B | 1.19B | 0.00 |
| Cost of Revenue | 4.05B | 3.59B | 2.84B | 3.14B | 2.20B | 2.20B | 2.01B | 1.86B | 1.80B | 2.12B | 1.88B | 1.54B | 1.27B | 1.24B | 1.02B | 772.76M | 0.00 |
| Gross Profit | 2.05B | 1.92B | 1.90B | 1.67B | 1.30B | 1.28B | 1.04B | 1.24B | 1.16B | 1.14B | 1.15B | 960.18M | 719.93M | 704.80M | 627.99M | 413.56M | 0.00 |
| Gross Profit Ratio | 33.54% | 34.92% | 40.10% | 34.72% | 37.15% | 36.83% | 34.13% | 40.02% | 39.16% | 34.95% | 38.01% | 38.37% | 36.19% | 36.19% | 38.21% | 34.86% | 0.00% |
| Research & Development | 0.00 | 6.43M | 6.65M | 5.94M | 291.00K | 187.00K | 48.00K | 40.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 104.56M | 91.48M | 85.48M | 85.58M | 74.06M | 53.42M | 51.54M | 0.00 | 0.00 | 0.00 | 39.55M | 29.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 94.04M | 93.07M | 202.52M | 182.17M | 138.91M | 143.29M | 151.27M | 0.00 | 0.00 | 0.00 | 135.37M | 106.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 542.67M | 184.54M | 288.00M | 267.75M | 212.97M | 196.71M | 202.80M | 305.82M | 322.05M | 313.92M | 455.72M | 384.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 866.68M | 30.65M | 10.71M | 9.01M | 63.00K | 25.70M | 1.26M | 932.10M | 925.45M | 915.73M | 846.31M | 744.95M | 569.88M | 587.29M | 558.50M | 466.09M | 0.00 |
| Operating Expenses | 1.42B | 1.48B | 1.13B | 938.77M | 914.48M | 881.81M | 801.78M | 932.10M | 925.45M | 915.73M | 846.31M | 744.95M | 569.88M | 587.29M | 558.50M | 466.09M | 0.00 |
| Cost & Expenses | 5.45B | 5.06B | 3.98B | 4.08B | 3.12B | 3.09B | 2.81B | 2.79B | 2.73B | 3.03B | 2.72B | 2.29B | 1.84B | 1.83B | 1.57B | 1.24B | 0.00 |
| Interest Income | 3.01M | 17.01M | 13.25M | 2.93M | 4.58M | 3.60M | 7.55M | 4.52M | 4.62M | 1.97M | 7.19M | 17.96M | 23.17M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 85.93M | 60.83M | 36.27M | 45.15M | 69.56M | 65.55M | 53.35M | 87.54M | 69.69M | 72.06M | 144.60M | 118.80M | 96.65M | 74.86M | 61.81M | 85.62M | 0.00 |
| Depreciation & Amortization | 129.03M | 127.28M | 111.16M | 102.07M | 95.77M | 87.39M | 85.13M | 83.31M | 81.18M | 96.43M | 129.21M | 124.63M | 118.04M | 116.22M | 115.46M | 113.69M | 0.00 |
| EBITDA | 868.18M | 548.77M | 980.11M | 997.82M | 467.72M | 493.92M | 399.93M | 418.74M | 314.55M | -165.12M | 426.10M | 354.61M | 268.08M | 233.73M | 184.95M | 61.16M | 0.00 |
| EBITDA Ratio | 14.23% | 9.96% | 20.29% | 20.58% | 13.18% | 14.26% | 12.69% | 14.41% | 9.11% | 9.84% | 14.33% | 13.58% | 13.48% | 12.00% | 11.25% | 5.16% | 0.00% |
| Operating Income | 675.45M | 452.84M | 769.17M | 724.08M | 380.42M | 402.51M | 238.06M | 250.39M | 107.19M | -391.24M | 171.78M | 111.19M | 150.04M | 117.50M | 69.49M | -52.53M | 0.00 |
| Operating Income Ratio | 11.07% | 8.22% | 16.22% | 15.04% | 10.86% | 11.54% | 7.81% | 8.08% | 3.62% | -12.01% | 5.67% | 4.44% | 7.54% | 6.03% | 4.23% | -4.43% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -104.65M | -87.09M | -9.21M | -763.56M | -126.22M | -540.80M | -337.33M | -100.73M | -96.65M | -74.86M | -61.81M | -85.61M | 0.00 |
| Income Before Tax | 675.45M | 360.66M | 817.81M | 833.36M | 282.84M | 316.63M | 228.85M | 250.39M | 107.19M | -391.24M | 171.78M | 111.19M | 53.40M | 42.64M | 7.68M | -138.14M | 0.00 |
| Income Before Tax Ratio | 11.07% | 6.55% | 17.24% | 17.31% | 8.07% | 9.08% | 7.51% | 8.08% | 3.62% | -12.01% | 5.67% | 4.44% | 2.68% | 2.19% | 0.47% | -11.64% | 0.00% |
| Income Tax Expense | 165.89M | 88.33M | 207.50M | 217.30M | 72.63M | 76.40M | 23.99M | 2.39M | -46.43M | 1.59M | -2.67K | -85.88K | 0.00 | -2.71M | 74.39M | -249.00K | 0.00 |
| Net Income | 509.56M | 272.33M | 610.31M | 616.06M | 210.20M | 240.23M | 204.86M | 248.00M | 107.19M | -391.24M | 171.78M | 111.19M | 53.40M | 48.60M | 4.75M | 137.89M | 0.00 |
| Net Income Ratio | 8.35% | 4.94% | 12.87% | 12.80% | 6.00% | 6.89% | 6.72% | 8.01% | 3.62% | -12.01% | 5.67% | 4.44% | 2.68% | 2.50% | 0.29% | 11.62% | 0.00% |
| EPS | 10.57 | 5.65 | 13.77 | 14.24 | 4.86 | 5.55 | 4.74 | 4.60 | 2.59 | -9.84 | 4.40 | 2.85 | 1.37 | 1.10 | -0.05 | 4.00 | 0.00 |
| EPS Diluted | 10.57 | 5.65 | 13.77 | 14.24 | 4.86 | 5.55 | 4.74 | 4.60 | 2.59 | -9.84 | 4.40 | 2.85 | 1.37 | 1.10 | -0.05 | 4.00 | 0.00 |
| Weighted Avg Shares Out | 48.21M | 48.21M | 44.31M | 43.25M | 43.25M | 43.25M | 43.25M | 43.25M | 41.40M | 39.76M | 39.05M | 39.05M | 39.05M | 39.05M | 36.22M | 35.25M | 43.25M |
| Weighted Avg Shares Out (Dil) | 48.21M | 48.21M | 44.31M | 43.25M | 43.25M | 43.25M | 43.25M | 43.25M | 41.40M | 39.76M | 39.05M | 39.05M | 39.05M | 39.05M | 36.22M | 35.25M | 43.25M |
Source: https://incomestatements.info
Category: Stock Reports